Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D00WHL
|
|||
Former ID |
DIB014990
|
|||
Drug Name |
Juvidex
|
|||
Synonyms |
Adaprev; Mannose-6-phosphate (scarring), Renovo
Click to Show/Hide
|
|||
Indication | Sarcoidosis [ICD-11: 4B20.5; ICD-10: D86.3] | Phase 2 | [1] | |
Company |
Renovo Group plc
|
|||
Structure |
Download2D MOL |
|||
Formula |
C6H13O9P
|
|||
Canonical SMILES |
C(C(C(C(C(C=O)O)O)O)O)OP(=O)(O)O
|
|||
InChI |
1S/C6H13O9P/c7-1-3(8)5(10)6(11)4(9)2-15-16(12,13)14/h1,3-6,8-11H,2H2,(H2,12,13,14)/t3-,4-,5-,6-/m1/s1
|
|||
InChIKey |
VFRROHXSMXFLSN-KVTDHHQDSA-N
|
|||
CAS Number |
CAS 3672-15-9
|
|||
PubChem Compound ID | ||||
ChEBI ID |
CHEBI:48042
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | CI Man-6-P receptor (IGF2R) | Target Info | Modulator | [2], [3] |
KEGG Pathway | Lysosome | |||
Panther Pathway | Apoptosis signaling pathway | |||
Insulin/IGF pathway-mitogen activated protein kinase kinase/MAP kinase cascade | ||||
Insulin/IGF pathway-protein kinase B signaling cascade | ||||
Reactome | Golgi Associated Vesicle Biogenesis | |||
WikiPathways | miR-targeted genes in muscle cell - TarBase | |||
miR-targeted genes in lymphocytes - TarBase | ||||
miR-targeted genes in leukocytes - TarBase | ||||
miR-targeted genes in epithelium - TarBase | ||||
miR-targeted genes in adipocytes - TarBase |
References | Top | |||
---|---|---|---|---|
REF 1 | ClinicalTrials.gov (NCT00984516) Investigation Into the Safety and Scar-improvement Efficacy of Intradermal Juvidex Dosed Once or Three Times. U.S. National Institutes of Health. | |||
REF 2 | Hypertrophic Scarring and Keloids: Pathomechanisms and Current and Emerging Treatment Strategies. Mol Med. 2011 Jan-Feb; 17(1-2): 113-125. | |||
REF 3 | Cation-independent mannose 6-phosphate receptor inhibitor (PXS25) inhibits fibrosis in human proximal tubular cells by inhibiting conversion of latent to active TGF-beta1. Am J Physiol Renal Physiol.2011 Jul;301(1):F84-93. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.